Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to firstname.lastname@example.org so that we can defer those challenges. Your health and safety are paramount to us.
Posted 30 January 2012 | By Alexander Gaffney, RAC
The US Department of Health and Human Services (DHHS) released new draft regulations on Friday, 27 January that would implement portions of the Patient Protection and Affordable Care Act (PPACA) by revising reimbursement methodologies for outpatient drugs covered by Medicaid.
Medicaid currently allows states to provide coverage of outpatient drugs to patients. Under the PPACA, DHHS is required to adjust the requirements for rebate agreements, drug pricing submission and confidentiality requirements, the formulas for calculating rebate payments, and other various requirements.
Tags: Provider, Outpatient, Medicaid, Pharmaceuticals, Coverage, Latest News, DHHS, CMS